• Rare and Inherited Diseases

    IRDs, Uveitis, and the Future of Care

    Read Issue
  •  
     
  • Diabetic Retinopathy
  • Retinal Disease Awareness News
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • Business Matters
  • AMD Disease Education Resource Center
  • diabetes awareness month
  • wet age-related macular degeneration month
  • Articles From This Issue

     

    UP FRONT

    Medical Editors’ Page

    Solutions To Difficult Diseases Will Be Here Soon

    The patients who linger in our minds the longest are those we cannot help. Despite the advances in our field, we still fail some of our most vulnerable patients. We can offe…

    Retina News

    Positive 2-Year Results Announced in LHON Gene Therapy Trial In the phase 3 REVERSE clinical trial, patients with Leber hereditary optic neuropathy (LHON) treated with GS010 (Ge…

    VISUALLY SPEAKING

    Choroideremia With Choroidal Neovascularisation

    A 48-year-old man presented with sudden loss of vision in his left eye (OS). He had a known history of choroideremia confirmed on genetic testing by a deletion in the CHM gene…

     

    Supplements and Inserts

    Insert

    AREDS Formulation: What We Know Now

    NEWS


     

    Researchers Test Stem Cell–Based Retinal Implant for Dry AMD With Encouraging Results

    Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for us…

    GenSight Biologics Announces Topline Results from Phase 3 Clinical Trial of GS010 in Patients with Leber Hereditary Optic Neuropathy (LHON)

    GenSight Biologics announced that a phase 3 study of GS010 (rAAV2/2-ND4) in patients with Leber hereditary optic neuropathy (LHON) failed to meet its primary endpoint, with sham-treated eyes demonstra…

    Treat-Extend-Stop Protocol for Wet AMD: Long-term Outcomes

    A retrospective chart review was performed for 71 eyes of 67 patients with neovascular age-related macular degeneration (AMD) treated with intravitreal anti-vascular endothelial growth factor (VEGF) i…

    Patients Regain Sight After Being First to Get Retinal Tissue Engineered From Stem Cells

    The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained reading vision, according to a report in VisionMonday. Th…

    Featured Content


    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Scott Krzywonos
    Editor-in-Chief
    484-581-1880
    skrzywonos@bmctoday.com

    Janet Burk
    Publisher
    214-394-3551
    jburk@bmctoday.com

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.